Skip to content
DraconiticResearch
Search Sources API
222,075 studies31 sourcesUpdated 27 min ago
Peer-reviewedLicence not statedScience signaling

Design of a new psychedelic quipazine analog with therapeutic efficacy and potentially fewer side effects

  • Jason Younkin1,2
  • Ajay H. Bansode3
  • Somdatta Saha1
  • Archana Paymode3
  • Jessica L. Maltman1,4
  • Charles B. Jones3
  • Justin M. Silverman1,4
  • Belle Buzzi1,4
  • Alaina M. Jaster1,4
  • Michael Fiorillo1,4
  • Jeremy Rolquin1,3
  • George D. Miller5
12 more authors
  • Roya Abedi5
  • Minho Kang1
  • Maya Gaines-Smith1,4
  • Enrique I. Valenzuela Lesme1
  • Mattias Embretsen1
  • Jennifer T. Wolstenholme1
  • Richard A. Glennon3
  • Hamid I. Akbarali1
  • M. Imad Damaj1
  • I. Scott Ramsey5
  • Małgorzata Dukat3
  • Javier González-Maeso1
5 affiliations
  1. 1Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
  2. 2Virginia institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23298, USA.
  3. 3Department of Medicinal Chemistry, Virginia Commonwealth University School of Pharmacy, Richmond, VA 23298, USA.
  4. 4Biomedical Sciences Graduate Program, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
  5. 5Department of Cellular, Molecular, and Genetic Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
Read full textDOICite

Related

  1. Chemical Design and Therapeutic Efficacy of HBsAg-Based Nanovaccines for Hepatitis B Virus Clearance: A Preclinical and Clinical Systematic Review
    Hasti Nequi Marnani, Tahereh Zadeh Mehrizi, Babak Eshrati +4
    Advanced Pharmaceutical BulletinPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMCEurope PMC
  2. Temporal and therapeutic confounders in predicting efficacy of immunotherapy rechallenge via baseline intratumoral tertiary lymphoid structures.
    Anran Sun, Hongkai Chen, Anyang Wei
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  3. Efficacy of a smartphone digital therapeutic (re-R) for post-total knee arthroplasty rehabilitation: study protocol for a single-center randomized controlled trial in the Republic of Korea
    Sung-Yeon Oh, Yeon-Gyo Nam
    TrialsPeer-reviewedCC BY-NC-ND 4.0Surgery & anaesthesiaCrossref
  4. Therapeutic efficacy and safety of newly approved FDA drug levoketoconazole in cushing syndrome: a systematic review
    Chiranjeevee R. Saravanan, Arvind Dinesh, Elizabeth Gaviria +6
    Annals of medicine and surgery (2012)Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner.
    Zhe Fu, Victoria Jackson-Patel, Kathryn Farrand +7
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textOncologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{younkin2026design,
  title = {{Design of a new psychedelic quipazine analog with therapeutic efficacy and potentially fewer side effects}},
  author = {Jason Younkin and Ajay H. Bansode and Somdatta Saha and Archana Paymode and Jessica L. Maltman and Charles B. Jones and Justin M. Silverman and Belle Buzzi and Alaina M. Jaster and Michael Fiorillo and Jeremy Rolquin and George D. Miller and Roya Abedi and Minho Kang and Maya Gaines-Smith and Enrique I. Valenzuela Lesme and Mattias Embretsen and Jennifer T. Wolstenholme and Richard A. Glennon and Hamid I. Akbarali and M. Imad Damaj and I. Scott Ramsey and Małgorzata Dukat and Javier González-Maeso},
  journal = {Science signaling},
  year = {2026},
  month = jul,
  doi = {10.1126/scisignal.adw6055},
  url = {https://doi.org/10.1126/scisignal.adw6055},
}
RIS
TY  - JOUR
TI  - Design of a new psychedelic quipazine analog with therapeutic efficacy and potentially fewer side effects
AU  - Jason Younkin
AU  - Ajay H. Bansode
AU  - Somdatta Saha
AU  - Archana Paymode
AU  - Jessica L. Maltman
AU  - Charles B. Jones
AU  - Justin M. Silverman
AU  - Belle Buzzi
AU  - Alaina M. Jaster
AU  - Michael Fiorillo
AU  - Jeremy Rolquin
AU  - George D. Miller
AU  - Roya Abedi
AU  - Minho Kang
AU  - Maya Gaines-Smith
AU  - Enrique I. Valenzuela Lesme
AU  - Mattias Embretsen
AU  - Jennifer T. Wolstenholme
AU  - Richard A. Glennon
AU  - Hamid I. Akbarali
AU  - M. Imad Damaj
AU  - I. Scott Ramsey
AU  - Małgorzata Dukat
AU  - Javier González-Maeso
PY  - 2026
DA  - 2026/07/21
JO  - Science signaling
DO  - 10.1126/scisignal.adw6055
UR  - https://doi.org/10.1126/scisignal.adw6055
SN  - 1945-0877
SN  - 1937-9145
ER  -